TC BioPharm targets AML relapse with innovative gamma-delta T cell therapy
Investing.com - 10-Feb-2025TC BioPharm’s Phase 2B trial shows TCB008 is safe with promising early effects in AML
Join the club for FREE to access the whole archive and other member benefits.
Global financial markets platform
Investing.com is a leading global financial markets platform founded in 2007, offering real-time data, quotes, charts, financial tools, breaking news, and analysis across over 250 exchanges worldwide. The platform provides access to more than 300,000 financial instruments, including stocks, commodities, cryptocurrencies, world indices, bonds, funds, ETFs, and world currencies. Available in 44 language editions, Investing.com serves over 46 million monthly users and generates more than 400 million sessions, making it one of the top three global financial websites according to SimilarWeb and Alexa.
Visit website: https://www.investing.com/
Details last updated 16-May-2025
TC BioPharm’s Phase 2B trial shows TCB008 is safe with promising early effects in AML